ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

Advanced Screening Provides More Accurate Diagnosis

February 23, 2007

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014

No Benefit To Kidney Removal For Elderly With Kidney Cancer

May 28, 2010

ASCO Study Predicts Shortage of Oncologists.

March 23, 2007

In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays

April 9, 1976

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005